Drug Profile
Research programme: bupropion metabolite - Biocopea Limited
Alternative Names: SD281Latest Information Update: 02 Apr 2024
Price :
$50
*
At a glance
- Originator Sosei
- Developer Biocopea
- Class Small molecules
- Mechanism of Action Interleukin 12 modulators; Tumour necrosis factor alpha modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammation